|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/685 | |||
| A61K 31/56 | |||
| A61P 9/10 | |||
| A61P 3/06 |
| (11) | Number of the document | 2588113 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11799979.7 |
| Date of filing the European patent application | 2011-06-30 | |
| (97) | Date of publication of the European application | 2013-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2011/000819 |
| Date | 2011-06-30 |
| (87) | Number | WO 2012/000048 |
| Date | 2012-01-05 |
| (30) | Number | Date | Country code |
| 359925 P | 2010-06-30 | US |
| (72) |
WRIGHT, Samuel, US
IMBODEN, Martin, CH
BOLLI, Reinhard, CH
WAELCHLI, Marcel, CH
|
| (73) |
CSL Limited,
45 Poplar Road, Parkville VIC 3052,
AU
|
| (54) | A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEREOF |
| A RECONSTITUTED HIGH DENSITY LIPOPROTEIN FORMULATION AND PRODUCTION METHOD THEREOF |